<DOC>
	<DOCNO>NCT00164710</DOCNO>
	<brief_summary>Sulfadoxine-pyrimethamine ( SP ) current first-line treatment uncomplicated malaria Malawi . The malaria parasite P. falciparum develop resistance drug drug much less effective previous year . This study develop conduct collaboration National Malaria Control Programme Malawi ass efficacy four antimalarial drug combination provide evidence assist Malawian Ministry Health identify implement policy next first-line antimalarial uncomplicated malaria Malawi . In open , randomized trial child five year age , four drug combination , license Malawi , assess : amodiaquine plus sulfadoxine-pyrimethamine ( AQ-SP ) , amodiaquine plus artesunate ( AQ-Art ) , chlorproguanil-dapsone plus artesunate ( CD-Art ) lumefantrine-artemether ( LA ) . SP also include fifth arm study current data efficacy . Data side effect drug also collect . The result study provide information necessary guide Malawi National Malaria Control Program select next first antimalarial treatment uncomplicated malaria . The study adhere World Health Organization 's 2003 standardized protocol assess antimalarial drug efficacy .</brief_summary>
	<brief_title>Assessing Efficacy Four Drug Combinations Next First-line Therapy Uncomplicated Malaria Malawi</brief_title>
	<detailed_description />
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Malaria , Falciparum</mesh_term>
	<mesh_term>Chlorproguanil</mesh_term>
	<mesh_term>Proguanil</mesh_term>
	<mesh_term>Lumefantrine</mesh_term>
	<mesh_term>Artemether</mesh_term>
	<mesh_term>Sulfadoxine</mesh_term>
	<mesh_term>Amodiaquine</mesh_term>
	<mesh_term>Dapsone</mesh_term>
	<mesh_term>Fanasil , pyrimethamine drug combination</mesh_term>
	<mesh_term>Pyrimethamine</mesh_term>
	<mesh_term>Artesunate</mesh_term>
	<mesh_term>Artemisinins</mesh_term>
	<criteria>Children age 6 59 month Axillary temperature ≥ 37.5 °C Monoinfection P. falciparum Parasitaemia 2000 200000 parasites/µl Haemoglobin concentration ( fingerprick blood sample HemoCue ) &gt; 7g/dl Consent patient 's adult guardian Residence locality willingness attend schedule visit alter consciousness convulsion prostration ( inability sit/stand/suck/drink ) respiratory distress breathlessness jaundice abnormal breathing haemoglobinuria circulatory collapse persistent vomiting ( keep liquid ) evidence diagnosis malaria physical examination presence mixed infection presence severe malnutrition ( evidenced symmetrical oedema involve least foot , light hair color , cachexia ) contraindication antimalarial drug use , especially history allergy history receive drug antimalarial activity week prior enrollment</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>59 Months</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>antimalarial</keyword>
</DOC>